Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Folotyn

(FOH-loh-tin)
A drug used to treat peripheral T-cell lymphoma (a fast-growing form of non-Hodgkin lymphoma) that recurred (came back) or did not get better with other anticancer therapy. It is also being studied in the treatment of other types of cancer. Folotyn stops cells from using folic acid to make DNA. This may help keep cancer cells from growing and may kill them. Folotyn is a type of antimetabolite and a type of dihydrofolate reductase inhibitor. Also called pralatrexate.
Search NCI's Dictionary of Cancer Terms